MYH9 and Nephropathy: Effective strategies to cure extra-hematological features of MYH9-RD, such as renin-angiotensin pathway inhibitors to slow nephropathy progression, or cochlear implantation to overcome profound deafness, have become available during the last decade for patients at risk for these complications [57,58].